Literature DB >> 9537026

Immunization with the light chain and the VL domain of the isologous myeloma protein 315 inhibits growth of mouse plasmacytoma MOPC315.

T Jørgensen1, G Gaudernack, K Hannestad.   

Abstract

Prior immunization of BALB/c mice with free light chains from myeloma protein 315 (L315) and its variable domain (VL315) inhibited the growth of subcutaneously injected MOPC315 tumour cells. The growth suppression observed after immunization with L315 was equivalent to that which resulted from immunization with the complete M315. VL315 and non-polymerized L315 did not elicit specific antibodies. Polymerized L315 induced both suppression of MOPC315 growth and antibodies specific for free L315; however, these antibodies did not react with the complete M315, nor were they absorbed by MOPC315 tumour cells. The data indicate that the suppression of tumour growth was mediated by specifically sensitized cells acting in the absence of antibodies against M315 or L315. Immunization with the variable domain of the heavy chain from M315 (VH315) had no effect on the growth of MOPC315. The M315 fragments and subunits that induced growth suppression were thus identical with those capable of inducing T helper cells in BALB/c mice.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 9537026     DOI: 10.1111/j.1365-3083.1980.tb00205.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  6 in total

Review 1.  Vaccination strategies for lymphomas.

Authors:  Mohammed M Dar; Larry W Kwak
Journal:  Curr Oncol Rep       Date:  2003-09       Impact factor: 5.075

2.  A small hypervariable segment in the variable domain of an immunoglobulin light chain stimulates formation of anti-idiotypic suppressor T cells.

Authors:  N Sakato; M Semma; H N Eisen; T Azuma
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

3.  Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response.

Authors:  L W Kwak; H A Young; R W Pennington; S D Weeks
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

4.  Naive idiotype-specific CD4+ T cells and immunosurveillance of B-cell tumors.

Authors:  G F Lauritzsen; S Weiss; Z Dembic; B Bogen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

Review 5.  Therapeutic vaccine for lymphoma.

Authors:  Seung-Tae Lee; Sattva S Neelapu; Larry W Kwak
Journal:  Yonsei Med J       Date:  2007-02-28       Impact factor: 2.759

Review 6.  Syngeneic antiidiotypic immune responses to a B cell lymphoma. Comparison between heavy chain hypervariable region peptides and intact Ig as immunogens.

Authors:  K Thielemans; J B Rothbard; S Levy; R Levy
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.